𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Carbidopa/levodopa–responsive myoclonus

✍ Scribed by David B. FitzGerald; Valeria Drago; Dean Sutherland; Kenneth M. Heilman

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
103 KB
Volume
22
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

A 64‐year‐old right‐handed woman's right hand and arm developed spontaneous jerks that eventually involved her trunk. As she had some features of parkinsonism, she was treated with carbidopa/levodopa and her myoclonus dramatically improved. The mechanism accounting for this improvement is unknown. © 2006 Movement Disorder Society

📜 SIMILAR VOLUMES

Cortical myoclonus in levodopa-responsiv
Cortical myoclonus in levodopa-responsive parkinsonism
✍ John N. Caviness; Charles H. Adler; Stephanie Newman; Richard J. Caselli; Manfre 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 469 KB

## Abstract We observed myoclonic movements of the fingers and wrists in two patients with a levodopa‐responsive parkinsonian syndrome most consistent with Parkinson's disease. These patients were studied with electrophysiological techniques. Brief (< 50 ms) myoclonic electromyographic discharges s

Fluctuations in plasma levodopa and moto
Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa
✍ L. Verhagen Metman; J. Hoff; M. M. Mouradian; Dr. T. N. Chase 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB

## Abstract To evaluate the ability of orally administered liquid levodopa/carbidopa (LD/CD) to stabilize plasma levodopa levels and reduce motor reponse fluctuations in Parkinson's disease, five patients received LD/CD hourly, as standard tablets or as an aqueous solution on two separate days in a

Double-blind trial of levodopa/carbidopa
Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease
✍ Robert A. Hauser; Michel Panisset; Giovanni Abbruzzese; Linda Mancione; Nalina D 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

## Abstract We performed a 39‐week, randomized, double‐blind, multicenter study to compare the efficacy, safety, and tolerability of levodopa/carbidopa/entacapone (LCE, Stalevo) with levodopa/carbidopa (LC, Sinemet IR) in patients with early Parkinson's disease (PD). Four hundred twenty‐three patie

Palatal myoclonus: Treatment with 5-hydr
Palatal myoclonus: Treatment with 5-hydroxytryptophan and carbidopa
✍ Mohit Bhatt; Barry Snow; Michael Varelas; Donald Calne 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

that an individual is less efficient at detoxifying MPTP and like compounds during first-pass metabolism, could leave a person at risk of toxicity. Slowly accumulating nigral damage would explain the tendency for the disease to increase in incidence with age, and differences in environmental dosage

Comparison of standard carbidopa–levodop
Comparison of standard carbidopa–levodopa and sustained-release carbidopa–levodopa in parkinson's disease: Pharmacokinetic and quality-of-life measures
✍ Dr. Rajesh Pahwa; Kelly Lyons; Desni McGuire; Paul Silverstein; Felix Zwiebel; M 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB

## Abstract We compared clinical, pharmacokinetic, and quality‐of‐life measures in patients with Parkinson's disease (PD) who were on standard carbidopa‐levodopa (Std‐L) and after conversion to sustained‐release carbidopa‐levodopa 50/200 (L‐CR). A total of 20 PD patients with motor fluctuations par